Multiplex Biomarker Imaging Market (By Component Type: Instruments, Software, Services; By Imaging Technique: Immunohistochemistry (IHC) Assay, Fluorescent In Situ Hybridization (FISH) Assay, Tissue Microarray (TMA) Assay) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Multiplex Biomarker Imaging Market 

5.1. COVID-19 Landscape: Multiplex Biomarker Imaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Multiplex Biomarker Imaging Market, By Component Type

8.1. Multiplex Biomarker Imaging Market, by Component Type, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Software

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Multiplex Biomarker Imaging Market, By Imaging Technique

9.1. Multiplex Biomarker Imaging Market, by Imaging Technique, 2023-2032

9.1.1. Immunohistochemistry (IHC) Assay

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Fluorescent In Situ Hybridization (FISH) Assay

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Tissue Microarray (TMA) Assay

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Multiplex Biomarker Imaging Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.1.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.1.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.1.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.2.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.2.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.2.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.2.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.2.6.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.3.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.3.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.3.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.3.6.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.4.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.4.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.4.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.4.6.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.5.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Component Type (2020-2032)

10.5.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)

Chapter 11. Company Profiles

11.1. Thermo Fisher Scientific Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Merck KGaA

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. PerkinElmer Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Illumina, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Abcam plc

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Agilent Technologies, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Bio-Rad Laboratories, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Ayoxxa Biosystems GmbH

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Akoya Biosciences, Inc.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Bio-Techne Corporation

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample